Novo - Passit tablets p / o, No. 30

• Neurasthenia and neurotic reactions, accompanied by irritability, anxiety, fear, fatigue, absent-mindedness.

• 'Manager's syndrome' (a state of constant mental stress).

• Insomnia (mild forms).

• Headaches due to nervous tension.

• Migraine.

• Functional diseases of the gastrointestinal tract (dyspeptic syndrome, irritable bowel syndrome).

• As a symptomatic remedy for neurocirculatory dystonia and climacteric syndrome.

• Itchy dermatoses (atopic and seborrheic eczema, urticaria) caused by psychological stress.

Inside, for adults and children over 12 years old:

In the absence of other doctor's recommendations, the drug should be taken 1 tablet 3 times a day before meals. After consulting a doctor, it is possible to increase the dose to 2 tablets 3 times a day. If severe fatigue or depression appears, it is necessary to reduce the morning and afternoon dose to 1/2 tablet for taking in the morning and afternoon, take 1 tablet in the evening. The interval between doses should be 4-6 hours. In case of nausea, the drug should be taken with meals.

Active ingredients:

Novo-Passita dry extract (obtained from rhizomes with roots of Valerian officinalis, lemon balm herb, St. John's wort, leaves and flowers of hawthorn or prickly hawthorn, Passiflora herb (passionflower), common hops, black elderberry flowers) 157.5 mg guaifenesin 200.0 mg

Excipients:

silicon dioxide 2.0 mg, microcrystalline cellulose 96.0 mg, glycerol 10.0 mg, magnesium stearate 10.0 mg, lactose monohydrate up to 800.0 mg

Sheath:

opadry 'AMV 80W31115' green (polyvinyl alcohol 45.52%, titanium dioxide 26.5%, talc 20.0%, soy lecithin 2.0%, xanthan gum 0.48%, quinoline yellow dye 2.5%, yellow iron oxide 2.0%, dye Indigo Carmip 1.0%) 24.0 mg

Hypersensitivity to the components of the drug, especially to guaifenesin, lactose intolerance, lactase deficiency, glucose-galactose malabsorption, myasthenia gravis, children under 12 years of age.

Carefully

Acute diseases of the gastrointestinal tract, liver diseases, alcoholism, diseases or injuries of the brain, epilepsy, children over 12 years of age. Application during pregnancy and during breastfeeding During pregnancy, the drug is prescribed only for absolute indications, if the expected effect for the mother outweighs the possible risk for the fetus. If it is necessary to use the drug during breastfeeding, breastfeeding should be discontinued.

Trade name:

Novo-PassitЃ

International non-proprietary or group name:

Dosage form:

film-coated tablets

Composition (for 1 tablet)

Active ingredients:

Novo-Passita dry extract (obtained from rhizomes with roots of Valerian officinalis, lemon balm herb, St. John's wort, leaves and flowers of hawthorn or prickly hawthorn, Passiflora herb (passionflower), common hops, black elderberry flowers) 157.5 mg guaifenesin 200.0 mg

Excipients:

silicon dioxide 2.0 mg, microcrystalline cellulose 96.0 mg, glycerol 10.0 mg, magnesium stearate 10.0 mg, lactose monohydrate up to 800.0 mg

Sheath:

opadry 'AMV 80W31115' green (polyvinyl alcohol 45.52%, titanium dioxide 26.5%, talc 20.0%, soy lecithin 2.0%, xanthan gum 0.48%, quinoline yellow dye 2.5%, yellow iron oxide 2.0%, dye Indigo Carmip 1.0%) 24.0 mg

Description

Tablets are oval, biconvex, coated with a pale green color, with a dividing line.

Pharmacotherapeutic group

Herbal sedative

ATX code: N05CM

pharmachologic effect

Combined drug, the pharmacological activity of which is due to the components of the extract based on medicinal plant materials with a predominantly sedative (sedative) effect and guaifenesin, which has anxiolytic (anti-anxiety) effect.

Indications for use

• Neurasthenia and neurotic reactions, accompanied by irritability, anxiety, fear, fatigue, absent-mindedness.

• 'Manager's syndrome' (a state of constant mental stress).

• Insomnia (mild forms).

• Headaches due to nervous tension.

• Migraine.

• Functional diseases of the gastrointestinal tract (dyspeptic syndrome, irritable bowel syndrome).

• As a symptomatic remedy for neurocirculatory dystonia and climacteric syndrome.

• Itchy dermatoses (atopic and seborrheic eczema, urticaria) caused by psychological stress.

Contraindications

Hypersensitivity to the components of the drug, especially to guaifenesin, lactose intolerance, lactase deficiency, glucose-galactose malabsorption, myasthenia gravis, children under 12 years of age.

Carefully

Acute diseases of the gastrointestinal tract, liver diseases, alcoholism, diseases or injuries of the brain, epilepsy, children over 12 years of age. Application during pregnancy and during breastfeeding During pregnancy, the drug is prescribed only for absolute indications, if the expected effect for the mother outweighs the possible risk for the fetus. If it is necessary to use the drug during breastfeeding, breastfeeding should be discontinued.

Method of administration and dosage

Inside, for adults and children over 12 years old:

In the absence of other doctor's recommendations, the drug should be taken 1 tablet 3 times a day before meals. After consulting a doctor, it is possible to increase the dose to 2 tablets 3 times a day. If severe fatigue or depression appears, it is necessary to reduce the morning and afternoon dose to 1/2 tablet for taking in the morning and afternoon, take 1 tablet in the evening. The interval between doses should be 4-6 hours. In case of nausea, the drug should be taken with meals.

Side effect

Patients usually tolerate the drug well. However, in rare cases, allergic reactions, exanthema, dizziness, fatigue, drowsiness, slight muscle weakness, disorders of the gastrointestinal tract (nausea, vomiting, spasms, heartburn, diarrhea, constipation), decreased concentration of attention, which quickly pass after drug withdrawal, may appear ...

If any of these side effects are aggravated, or you notice any other side effects that are not listed in the instructions, inform your doctor.

Overdose

Overdose initially manifests itself as a feeling of depression and drowsiness. Later, these symptoms may be accompanied by nausea, mild muscle weakness, joint pain, and a feeling of heaviness in the stomach. If symptoms of an overdose appear, the drug should be discontinued. First aid: gastric lavage. Treatment is symptomatic. You need to see a doctor.

Interaction with other medicinal products

With the simultaneous administration of Novo-PassitЃ and other drugs, their effect may be enhanced or weakened. Before you start taking the drug at the same time as other drugs, you should consult your doctor.

The drug enhances the effect of alcohol and other substances that depress the central nervous system.

Medicines used to relax skeletal muscles (central muscle relaxation) may increase the risk of side effects of the drug, primarily muscle weakness.

St. John's wort extract contained in the preparation reduces the effectiveness of hormonal contraception, as well as drugs used mainly after transplantation to reduce the risk of rejection of the transplanted organ or tissue (immunosuppressive drugs), drugs intended for the treatment of AIDS, cardiovascular diseases, bronchial diseases and prevention of thrombosis -boembolism. Therefore, before you start taking Novo-Passit against the background of these drugs, you should consult your doctor.

special instructions

During treatment with the drug, you should not consume alcoholic beverages.

While taking Novo-Passit, especially for patients with fair skin, you should avoid exposure to ultraviolet radiation (prolonged exposure to direct sunlight, visiting a solarium).

If the symptoms of the disease persist or the condition worsens while using the drug for 7 days, you should inform your doctor about it. Influence on the ability to drive vehicles and mechanisms During the period of use of the drug, one should refrain from performing potentially hazardous activities that require increased concentration of attention and speed of psychomotor reactions (including driving, working with moving mechanisms).

Release form

Film-coated tablets.

30, 60 or 100 tablets in a polyethylene jar with a seal and a screw cap or 10 tablets in a blister (A1 / PVC). Each can, 1 or 3 blisters are placed in a cardboard box along with instructions for use.

Storage conditions

At a temperature of 10 ? to 25 ? C, in a dark place. Keep out of the reach of children.

Shelf life

3 years.

Do not use after the expiration date.

Vacation conditions

Without recipe.